[Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
Lebedeva
V V
VV
Gmoshinskiĭ
I V
IV
Mazo
V K
VK
Murav'ev
Iu V
IuV
D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D005260:Female; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects* / Q000502:physiology; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000502:physiology; D007421:Intestine, Small / Q000187:drug effects / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010047:Ovalbumin / Q000493:pharmacokinetics; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D055815:Young Adult
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010047:Ovalbumin